Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme
Clinical trial NCT00892931 · COMPLETED
Trial details
- NCT number
- NCT00892931
- Sponsor
- Myrexis Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2011-07-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.